Good afternoon, everyone, and welcome.
We are here today, pursuant to Standing Order 108(2), to continue our study of the Atomic Energy of Canada facility at Chalk River and the status of the production of medical isotopes.
We have today four groups of witnesses. I will introduce the groups one at a time, just before they make their presentations. We will proceed in the order the individuals or groups are on the agenda. So we'll start today with Linda Keen, specialist in safety and risk management, who's here as an individual.
Go ahead, please, Ms. Keen, for about 10 minutes.